Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
22 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
Not establishedNo committee role is currently confirmed by the cited sources
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Senior Counsel at Davis Polk with extensive experience in mergers and acquisitions and corporate governance. Served as global co-chairman of Davis Polk's M&A practice and on the board of Emerson Electric from 2000 to 2024.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

NEW YORK TIMES CO

2021-01-01 · current

Confirmed by public sourceView source

Director

Turn Therapeutics Inc.

Current · start date not disclosed

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

NEW YORK TIMES CO

Open NEW YORK TIMES CO profile →

Director at NEW YORK TIMES CO

2021-01-01 → End not stated

current · source reported

Observed: 2026-09-21

NEW YORK TIMES CONEW YORK TIMES COTurn Therapeutics …Turn Therapeutics Inc.Arthur Golden

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingTTRX 10-K executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Other Company Role, Technology background.Open sourceSource 2 · Sec ProxyPublic profile sourceSupports Director at NEW YORK TIMES CO (NYSE: NYT).Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:arthur-golden
Record version
public-0

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board membership · Source reportedServes on the board of NEW YORK TIMES CO1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of Turn Therapeutics Inc.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at Turn Therapeutics Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Director1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Other Company Role · Source reportedArthur Golden is also linked to Davis Polk Wardwell LLP as Senior Counsel.1 source
Verification
Source reported
Confidence
70%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources5 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Other Company Role · Technology background

  2. https://www.sec.gov/Archives/edgar/data/2023016/000121390026037505/ea0281342-10k_turntherap.htm

    Sec 10k · Tier not stated · Reviewed Sep 14, 2026

    Supports: Director at Turn Therapeutics Inc. (NASDAQ: TTRX)

  3. https://www.sec.gov/Archives/edgar/data/71691/000007169126000016/nyt-20260313.htm

    Sec Proxy · Tier not stated · Reviewed Jul 12, 2026

    Supports: Director at NEW YORK TIMES CO (NYSE: NYT)

  4. https://www.sec.gov/Archives/edgar/data/71691/000007169126000016/nyt-20260313.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  5. https://www.sec.gov/Archives/edgar/data/2023016/000121390026037505/ea0281342-10k_turntherap.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership